TY - JOUR
AR - SCR-2020-12-101
TI - Epoprostenol & Its Use in Microvascular Surgery – A Useful Aid to Flap Salvage Secondary to Recalcitrant Vasospasm?
AU - Suzanne , Beecher
AU - Gráinne , Bourke
AU - E Jason , Kelly
JO - Surgical Case Reports
PY - 2020
DA - Tue 01, Dec 2020
SN - 2613-5965
DO - http://dx.doi.org/10.31487/j.SCR.2020.12.01
UR - https://www.sciencerepository.org/epoprostenol-and-its-use-in-microvascular-surgery-a-useful-aid_SCR-2020-12-101 
KW - Epoprostenol, flap salvage, vasospasm, microsurgery, thrombosis
AB - Systemic intravenous epoprostenol, as well as being a vasodilator, is the most potent inhibitor of platelet
aggregation known. Early research carried out on its use in microvascular surgery showed promising results
in preventing thrombosis and improving flap survival rates, however interest in its use in microsurgery has
diminished in recent years. In this report we describe its use in successful free flap salvage and discuss its
role in microsurgery.